Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04913337
Title Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NGM Biopharmaceuticals, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
NGM Clinical Study Site Los Angeles California 90033 United States Details
NGM Clinical Study Site Newport Beach California 92663 United States Details
NGM Clinical Study Site Santa Monica' California 90404 United States Details
NGM Clinical Study Site Santa Rosa California 94505 United States Details
NGM Clinical Study Site Lone Tree Colorado 80124 United States Details
NGM Clinical Study Site Washington District of Columbia 20007 United States Details
NGM Clinical Study Site Sarasota Florida 34232 United States Details
NGM Clinical Study Site Baltimore Maryland 21201 United States Details
NGM Clinical Study Site Boston Massachusetts 02215 United States Details
NGM Clinical Study Site Grand Rapids Michigan 49546 United States Details
NGM Clinical Study Site Omaha Nebraska 68130 United States Details
NGM Clinical Study Site Albany New York 12206 United States Details
NGM Clinical Study Site Greenville South Carolina 29605 United States Details
NGM Clinical Study Site Dallas Texas 75246 United States Details
NGM Clinical Study Site Dallas Texas 78701 United States Details
NGM Clinical Study Site Houston Texas 77030 United States Details
NGM Clinical Study Site San Antonio Texas 78229 United States Details
NGM Clinical Study Site San Antonio Texas 78240 United States Details
NGM Clinical Study Site Blacksburg Virginia 24060 United States Details
NGM Clinical Study Site Vancouver Washington 98684 United States Details
NGM Clinical Study Site Seoul 03080 Korea, Republic of Details
NGM Clinical Study Site Seoul 05505 Korea, Republic of Details
NGM Clinical Study Site Seoul 06351 Korea, Republic of Details
NGM Clinical Study Site New Taipei City 235 Taiwan Details
NGM Clinical Study Site Taichung 404327 Taiwan Details
NGM Clinical Study Site Tainan 704 Taiwan Details
NGM Clinical Study Site Taipei 100225 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field